I'm with you there Caketin. This is showing total profit of 55%...

I'm with you there Caketin. This is showing total profit of 55% (split equally with Dr Reddy) which is higher than I recall being discussed.

The thing is that the number they are reporting is Net Sales (33m) - my estimate of gross sales for the Fonda (based on a line fit through the reported weekly sales from IMS) was $56m.

Assuming the weekly sales stay at that reported for week of 25th May ($1.8m to ACL/DRD), that is looking like gross sales of 94 million in FY13 (at current market share), and PBT of $15m before the $2m investment on improving the current process (assuming $9m was ACL share of the development costs). NPAT in FY13 will depend on claimable accumulated losses.